首页/数据集/Correlations between clinical findings and Fpn1 protein levels in patients with CHC.

Correlations between clinical findings and Fpn1 protein levels in patients with CHC.

NIAID Data Ecosystem2026-03-09 收录

数据链接：

https://figshare.com/articles/dataset/_Correlations_between_clinical_findings_and_Fpn1_protein_levels_in_patients_with_CHC_/1210639 数据链接链接失效反馈

官方服务：

资源简介：

Correlations between clinical findings and Fpn1 protein levels in patients with CHC.

应用场景：

创建时间：

2014-10-20

非酒精性脂肪性肝病生物标志物

血清microRNA诊断验证

Liver biopsy is currently the only reliable method to establish non‐alcoholic fatty liver disease (NAFLD) severity. However, this technique is invasive and occasionally associated with severe complica

NIAID Data Ecosystem60

Data_Sheet_1_Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk.docx

非酒精性脂肪性肝病生物标志物

心脏代谢风险

Background: Liver steatosis is considered the onset of the non-alcoholic fatty liver disease (NAFLD), a major public health challenge. Nevertheless, NAFLD detection and diagnosis remain a difficult ta

NIAID Data Ecosystem40

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: diagnostic and mechanistic relevance

非酒精性脂肪性肝病生物标志物

miRNA表达谱分析

Background & Aims: Serum microRNAs (miRNAs) levels are known to change in non-alcoholic fatty liver disease (NAFLD) and may serve as useful biomarkers. This study aimed to profile miRNAs comprehensiv

NIAID Data Ecosystem30

Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease

非酒精性脂肪性肝病生物标志物

MicroRNA表达

Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of progressing to fibrosis and cirrhosis. Th

NIAID Data Ecosystem50

Metagenomic signatures in the European NAFLD registry metacohort cases

微生物组诊断

非酒精性脂肪性肝病生物标志物

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in developed countries, and its prevalence continues to rise in association with the global obesity and diabetes pand

NIAID Data Ecosystem30

Correlations between clinical findings and Fpn1 protein levels in patients with CHC.

资源简介：

相关数据集